DOI: 10.1111/apt.16251 ISSN:

Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir—new clues from Europe. Authors' reply

Stanislas Pol, Clovis Luzivika Nzinga, Hélène Fontaine, Fabrice Carrat,
  • Pharmacology (medical)
  • Gastroenterology
  • Hepatology
Show PDF Cite

LINKED CONTENT

This article is linked to Pol et al and Lampertico & Papatheodoridis papers. To view these articles, visit https://doi.org/10.1111/apt.16197 and https://doi.org/10.1111/apt.16238

More from our Archive